Home / Clindamycin / United States
US ATC D10AF01 · updated 2 Nov 2026
Clindamycin shortage in United States
Is there a Clindamycin shortage in United States?
Yes. As of 2 Nov 2026, 22 Clindamycin products are reported short in United States, the first since 21 Mar 2023. No return date has been given. Main reason: not stated.
Also short in Canada, Spain, Japan. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09) | Sandoz Inc. | 21 Mar 2023 | not given | Not stated |
| US | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24) | Sandoz Inc. | 21 Mar 2023 | not given | Not stated |
| US | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09) | Sandoz Inc. | 21 Mar 2023 | not given | Not stated |
| US | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24) | Sandoz Inc. | 21 Mar 2023 | not given | Not stated |
| US | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09) | Sandoz Inc. | 21 Mar 2023 | not given | Not stated |
| US | Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26) | Pfizer Inc. | 21 Mar 2023 | not given | Other |
| US | Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26) | Pfizer Inc. | 21 Mar 2023 | not given | Other |
| US | Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18) | Pfizer Inc. | 21 Mar 2023 | not given | Other |
| US | Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-3410-50) | Baxter Healthcare | 21 Mar 2023 | not given | Not stated |
| US | Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9545-50) | Baxter Healthcare | 21 Mar 2023 | not given | Not stated |
| US | Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50) | Baxter Healthcare | 21 Mar 2023 | not given | Not stated |
| US | Clindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50) | Baxter Healthcare | 21 Mar 2023 | not given | Not stated |
| US | Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50) limited | Baxter Healthcare | 21 Mar 2023 | not given | Other |
| US | Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-9553-50) | Baxter Healthcare | 21 Mar 2023 | not given | Not stated |
| US | Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19) discontinuation | Amneal Pharmaceuticals | 27 Feb 2026 | not given | Not stated |
| US | Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19) discontinuation | Amneal Pharmaceuticals | 26 Mar 2026 | not given | Not stated |
| US | Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial (NDC 0009-0870-26) discontinuation | Pfizer Inc. | 1 Jun 2026 | not given | Not stated |
| US | Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial NovaPlus (NDC 0009-3051-02) discontinuation | Pfizer Inc. | 1 Jun 2026 | not given | Not stated |
| US | Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial (NDC 0009-0775-26) discontinuation | Pfizer Inc. | 1 Jun 2026 | not given | Not stated |
| US | Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial NovaPlus (NDC 0009-4073-04) discontinuation | Pfizer Inc. | 1 Jun 2026 | not given | Not stated |
| US | Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial (NDC 0009-0902-18) discontinuation | Pfizer Inc. | 1 Jun 2026 | not given | Not stated |
| US | Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial NovaPlus (NDC 0009-5095-06) discontinuation | Pfizer Inc. | 1 Jun 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).